News

August 02, 2016

Dr. Ron Korn involved in study published to PubMed.
Abstract
PURPOSE:
To evaluate the feasibility of constructing radiogenomic-based... full article

May 04, 2016

Imaging to Cure Cancer: Valuable Contribution of Radiology for Clinical Trial Success
Written by Dr. Ron Korn, Founder, Chairman and Chief Medical Officer at Imaging Endpoints

“I keep dreaming of a future, a future with a long and healthy life, not lived in the shadow of cancer but in the... full article

April 06, 2016

11th Annual TOP Conference – Don’t Forget Clinical Trials

Imaging Endpoints CMO and Founder, Ronald Korn, MD., Ph.D. presents “New Imaging Techniques to Aid Creative Clinical Trial Designs.” ... full article

March 03, 2016

Dr. Ron Korn, founder and Chief Medical Officer of Imaging Endpoints Core Lab will be a featured speaker at the Cancer Treatment Centers of America® (CTCA) Western Regional Medical Center (Western) Annual New Treatments in Oncology (ANTO) conference. This conference focuses on advances in cancer research, new treatments and patient care. 

February 02, 2016

Immuno-Oncology 360°

Imaging Endpoints CMO and Founder, Ronald Korn, MD., Ph.D. presents “Imaging the Immune System in Solid Tumors.”... full article

March 13, 2015

Radiogenomics should be an integral part of drug development, according to Dr Korn who talks to ecancer about this evolving field at TAT 2015.

July 03, 2014

TGen, Scottsdale Healthcare, and Cancer Centers of America are leading new research studies for patients suffering with lung cancer.

May 07, 2014

Boston, MA – May 7, 2014 – AG Mednet and the board-certified, fellowship-trained radiologists at Imaging Endpoints believe strongly that every clinical trial data point counts, from pre-clinical through FDA submission. To support its guarantee of accuracy, compliance, real-time reads and sponsor confidence, Imaging Endpoints is utilizing AG... full article

Pages